Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies.

Multiple Cancer Types

Breast, Colon, Lung, Melanoma, Non Small Cell, Ovarian, Phase I, Rectal
I
Berlin, Jordan
NCT04244552
VICCPHI2040

To learn more about any of our clinical
trials, call 615-936-8422.